The A5322 protocol is a long-term observational study, with a planned series of analyses of data to be collected from an...
The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
